-
Leveraging the strengths of private and public sectors through resource pooling, innovative distribution models, and infrastructure development to enhance supply chain resilience, optimize the allocation of pharmaceutical products, and promote equitable access to essential medicines.
Cross-Sector Emergency Stockpile Partnerships
Establishing joint emergency stockpiles in partnership with government agencies, NGOs, and private entities to maintain critical drug reserves. These stockpiles could be dynamically distributed to areas in urgent need, minimizing shortages during crises.
Integrated Supply Chain and Inventory Data Network
Developing a data-sharing network across pharmaceutical manufacturers, distributors, and healthcare providers to track supply and demand in real time. This enables stakeholders to make data-driven decisions to prevent both surplus and shortage situations.
Global Pharma Surplus Redistribution Network
Building a surplus redistribution network that connects facilities with surplus medications to those experiencing shortages, both locally and internationally. Through this network, participants can share stock where it is most needed, ensuring that excess inventory benefits underserved regions.
Public-Private Subsidy Programs for Rural Access
Forming public-private partnerships to develop subsidy programs that cover distribution costs or provide essential medications at reduced prices in underserved areas. This partnership can make medications more accessible to low-income populations without increasing financial burdens on pharmacies.
Localized Production Partnerships with NGOs and Government
Partnering with local governments and NGOs to establish small-scale, locally-managed production units for essential drugs. This can reduce dependency on large-scale imports, cut down transportation delays, and support quicker response times for urgent needs.